Literature DB >> 25204416

Assessment of diabetic peripheral neuropathy in streptozotocin-induced diabetic rats with magnetic resonance imaging.

Dongye Wang1, Xiang Zhang, Liejing Lu, Haojiang Li, Fang Zhang, Yueyao Chen, Jun Shen.   

Abstract

OBJECTIVE: To determine the role of magnetic resonance (MR) imaging and quantitative T2 value measurements in the assessment of diabetic peripheral neuropathy (DPN).
METHODS: Sequential MR imaging, T2 measurement, and quantitative sensory testing of sciatic nerves were performed in streptozotocin-induced diabetic rats (n = 6) and normal control rats (n = 6) over a 7-week follow-up period. Histological assessment was obtained from 48 diabetic rats and 48 control rats once weekly for 7 weeks (n = 6 for each group at each time point). Nerve signal abnormalities were observed, and the T2 values, mechanical withdrawal threshold (MWT), and histological changes were measured and compared between diabetic and control animals.
RESULTS: Sciatic nerves in the diabetic rats showed a gradual increase in T2 values beginning at 2 weeks after the induction (P = 0.014), while a decrease in MWT started at 3 weeks after the induction (P = 0.001). Nerve T2 values had a similar time course to sensory functional deficit in diabetic rats. Histologically, sciatic nerves of diabetic rats demonstrated obvious endoneural oedema from 2 to 3 weeks after the induction, followed by progressive axonal degeneration, Schwann cell proliferation, and coexistent disarranged nerve regeneration.
CONCLUSION: Nerve T2 measurement is potentially useful in detecting and monitoring diabetic neuropathy. KEY POINTS: • Sciatic nerves in diabetic rats showed a gradual increase in T2 values • Nerve T2 values were negatively correlated with sensory function impairment • Longitudinal T2 values can be used to monitor the disease progress • Nerve degeneration contributed mainly to progressive prolongation of nerve T2 values.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25204416     DOI: 10.1007/s00330-014-3423-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

1.  Diabetic neuropathy.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2008-03       Impact factor: 19.112

2.  Magnetic resonance imaging monitoring of peripheral nerve regeneration following neurotmesis at 4.7 Tesla.

Authors:  Björn Behr; Reinhild Schnabel; Ursula Mirastschijski; Bchar Ibrahim; Frank Angenstein; Wolfgang Schneider
Journal:  Plast Reconstr Surg       Date:  2009-06       Impact factor: 4.730

3.  Peripheral nerve repair: monitoring by using gadofluorine M-enhanced MR imaging with chitosan nerve conduits with cultured mesenchymal stem cells in rat model of neurotmesis.

Authors:  Cheng-De Liao; Fang Zhang; Ruo-Mi Guo; Xiao-Mei Zhong; Jun Zhu; Xue-Hua Wen; Jun Shen
Journal:  Radiology       Date:  2011-11-04       Impact factor: 11.105

4.  Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis.

Authors:  R P Eaton; C Qualls; J Bicknell; W L Sibbitt; M K King; R H Griffey
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

5.  Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats.

Authors:  Hiroko Yamamoto; Yukinori Shimoshige; Takayuki Yamaji; Nobuhito Murai; Toshiaki Aoki; Nobuya Matsuoka
Journal:  Neuropharmacology       Date:  2009-07-09       Impact factor: 5.250

6.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

7.  Animal models of painful diabetic neuropathy: the STZ rat model.

Authors:  Thomas J Morrow
Journal:  Curr Protoc Neurosci       Date:  2004-11

Review 8.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

Review 9.  Magnetic resonance imaging of the peripheral nervous system.

Authors:  Guido Stoll; Martin Bendszus; Jose Perez; Mirko Pham
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

10.  Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosin.

Authors:  Harun Alp; Sefer Varol; Muhammet Murat Celik; Murat Altas; Osman Evliyaoglu; Orhan Tokgoz; Mehmet Halis Tanrıverdi; Ertugrul Uzar
Journal:  Exp Diabetes Res       Date:  2012-01-16
View more
  4 in total

1.  Assessment of tibial and common peroneal nerves in diabetic peripheral neuropathy by diffusion tensor imaging: a case control study.

Authors:  Chao Wu; Guangbin Wang; Yunxia Zhao; Wen Hao; Lianxin Zhao; Xinjuan Zhang; Jinfeng Cao; Shanshan Wang; Weibo Chen; Queenie Chan; Bin Zhao; Avneesh Chhabra
Journal:  Eur Radiol       Date:  2016-12-21       Impact factor: 5.315

2.  MR T2 value of the tibial nerve can be used as a potential non-invasive and quantitative biomarker for the diagnosis of diabetic peripheral neuropathy.

Authors:  Dongye Wang; Chuan Wang; Xiaohui Duan; Zehong Yang; Zhiqiang Bai; Huijun Hu; Li Yan; Jun Shen
Journal:  Eur Radiol       Date:  2017-10-16       Impact factor: 5.315

3.  Characterization of experimental diabetic neuropathy using multicontrast magnetic resonance neurography at ultra high field strength.

Authors:  Daniel Schwarz; Asa S Hidmark; Volker Sturm; Manuel Fischer; David Milford; Ingrid Hausser; Felix Sahm; Michael O Breckwoldt; Nitin Agarwal; Rohini Kuner; Martin Bendszus; Peter P Nawroth; Sabine Heiland; Thomas Fleming
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

4.  Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy.

Authors:  Adel Ben-Kraiem; Reine-Solange Sauer; Carla Norwig; Maria Popp; Anna-Lena Bettenhausen; Mariam Sobhy Atalla; Alexander Brack; Robert Blum; Kathrin Doppler; Heike Lydia Rittner
Journal:  J Mol Med (Berl)       Date:  2021-05-21       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.